No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Wedbush Maintains CytomX(CTMX.US) With Buy Rating, Cuts Target Price to $5
CytomX Therapeutics (CTMX) Receives a Buy From Wedbush
Express News | CytomX Therapeutics Inc : Wedbush Cuts Target Price to $5 From $8
HC Wainwright & Co. Reiterates Neutral on CytomX Therapeuticsto Neutral
Barclays Maintains CytomX(CTMX.US) With Buy Rating, Maintains Target Price $3.5
CytomX Therapeutics to Cut 40% of Workforce